Scott D. Ramsey, PhD, MD

Quintiles Senior Fellow, USC Schaeffer Center
Director, Hutchinson Institute for Cancer Outcomes Research
Professor, School of Medicine, School of Pharmacy and the Institute for Public Health Genetics, University of Washington

Scott D. Ramsey, PhD, MD's Bio

Scott D. Ramsey, PhD, MD, is a general internist and health economist. He is a full member in of the Fred Hutchinson Cancer Research Center, where he directs the Hutchinson Institute for Cancer Outcomes Research, a multidisciplinary team devoted to clinical and economic evaluations of new and existing cancer prevention, screening and treatment technologies. He is also a professor in the School of Medicine, School of Pharmacy and the Institute for Public Health Genetics at the University of Washington.

His research focuses on economic evaluations in cancer, large-scale SEER-Medicare/Cancer Registry data linkages, patient-reported outcomes, economic modeling of healthcare interventions, cost-effectiveness analysis, quality-of-life assessment, patterns of care, healthcare utilization, economic burden of disease for patients and society, pragmatic trial design, early technology assessment and stakeholder engagement. He has published widely on patterns of care, costs and cost-effectiveness of treatments for lung, colorectal and prostate cancer.

Ramsey has been part of a National Cancer Institute study partnering with the Southwest Oncology Group to bring comparative effectiveness principles to cooperative group trials; a study examining bankruptcy among persons with cancer; developing a genetic screening policy model for colorectal cancer; an evaluation of decision-making for men newly diagnosed with prostate cancer; an investigation of cancer screening, incidence, treatment and outcomes for Native Americans; and evaluating the economic impact of bone marrow transplants from the perspective of patients and families, health insurers and society.

He is co-chair of the Outcomes and Comparative Effectiveness Committee of the Southwest Oncology Group, past president of the International Society of Pharmacoeconomics and Outcomes Research, and has served on the Institute of Medicine Cancer Policy Forum.

He earned a BS and MD from the University of Iowa and a PhD in health economics from the University of Pennsylvania.

Recent Work